Logo image of UPXI

UPEXI INC (UPXI) Stock Fundamental Analysis

NASDAQ:UPXI - Nasdaq - US39959A2050 - Common Stock - Currency: USD

7.24  -0.02 (-0.28%)

After market: 7.41 +0.17 (+2.35%)

Fundamental Rating

2

Taking everything into account, UPXI scores 2 out of 10 in our fundamental rating. UPXI was compared to 35 industry peers in the Personal Care Products industry. Both the profitability and financial health of UPXI have multiple concerns. UPXI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year UPXI has reported negative net income.
In the past year UPXI has reported a negative cash flow from operations.
In the past 5 years UPXI reported 4 times negative net income.
In multiple years UPXI reported negative operating cash flow during the last 5 years.
UPXI Yearly Net Income VS EBIT VS OCF VS FCFUPXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of UPXI (-149.36%) is worse than 94.29% of its industry peers.
UPXI has a worse Return On Equity (-1215.98%) than 85.71% of its industry peers.
Industry RankSector Rank
ROA -149.36%
ROE -1215.98%
ROIC N/A
ROA(3y)-43.82%
ROA(5y)-40.96%
ROE(3y)-143.38%
ROE(5y)-551.09%
ROIC(3y)N/A
ROIC(5y)N/A
UPXI Yearly ROA, ROE, ROICUPXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

UPXI's Gross Margin of -16.17% is on the low side compared to the rest of the industry. UPXI is outperformed by 91.43% of its industry peers.
UPXI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for UPXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -16.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y0.94%
UPXI Yearly Profit, Operating, Gross MarginsUPXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UPXI has less shares outstanding
UPXI has less shares outstanding than it did 5 years ago.
UPXI has a worse debt/assets ratio than last year.
UPXI Yearly Shares OutstandingUPXI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
UPXI Yearly Total Debt VS Total AssetsUPXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 2.95 indicates that UPXI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.95, UPXI perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
UPXI has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.31, UPXI perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 2.95
ROIC/WACCN/A
WACC8.74%
UPXI Yearly LT Debt VS Equity VS FCFUPXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 0.37 indicates that UPXI may have some problems paying its short term obligations.
UPXI's Current ratio of 0.37 is on the low side compared to the rest of the industry. UPXI is outperformed by 94.29% of its industry peers.
UPXI has a Quick Ratio of 0.37. This is a bad value and indicates that UPXI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of UPXI (0.24) is worse than 94.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.24
UPXI Yearly Current Assets VS Current LiabilitesUPXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for UPXI have decreased strongly by -311.61% in the last year.
Looking at the last year, UPXI shows a very negative growth in Revenue. The Revenue has decreased by -121.06% in the last year.
The Revenue has been growing by 63.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-311.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.78%
Revenue 1Y (TTM)-121.06%
Revenue growth 3Y2.56%
Revenue growth 5Y63.73%
Sales Q2Q%-78.12%

3.2 Future

The Earnings Per Share is expected to grow by 41.10% on average over the next years. This is a very strong growth
UPXI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -48.66% yearly.
EPS Next Y30.61%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.09%
Revenue Next 2Y-48.66%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UPXI Yearly Revenue VS EstimatesUPXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
UPXI Yearly EPS VS EstimatesUPXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

UPXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year UPXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UPXI Price Earnings VS Forward Price EarningsUPXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UPXI Per share dataUPXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as UPXI's earnings are expected to grow with 41.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.1%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UPXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UPEXI INC

NASDAQ:UPXI (7/17/2025, 8:00:02 PM)

After market: 7.41 +0.17 (+2.35%)

7.24

-0.02 (-0.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-16 2025-05-16
Earnings (Next)09-22 2025-09-22/amc
Inst Owners0.05%
Inst Owner Change0%
Ins Owners10.84%
Ins Owner Change0%
Market Cap274.54M
Analysts43.33
Price Target25.5 (252.21%)
Short Float %3.75%
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-80.04%
Min Revenue beat(2)-82.88%
Max Revenue beat(2)-77.19%
Revenue beat(4)0
Avg Revenue beat(4)-137.29%
Min Revenue beat(4)-315.64%
Max Revenue beat(4)-73.46%
Revenue beat(8)0
Avg Revenue beat(8)-80.91%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 148.34
P/tB 354.34
EV/EBITDA N/A
EPS(TTM)-20.73
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS-0.58
BVpS0.05
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -149.36%
ROE -1215.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -16.17%
FCFM N/A
ROA(3y)-43.82%
ROA(5y)-40.96%
ROE(3y)-143.38%
ROE(5y)-551.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y0.94%
F-Score2
Asset Turnover-1.46
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 111.19%
Cap/Sales -1.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.24
Altman-Z 2.95
F-Score2
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)81.08%
Cap/Depr(5y)139.5%
Cap/Sales(3y)9.46%
Cap/Sales(5y)12.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-311.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.78%
EPS Next Y30.61%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-121.06%
Revenue growth 3Y2.56%
Revenue growth 5Y63.73%
Sales Q2Q%-78.12%
Revenue Next Year8.09%
Revenue Next 2Y-48.66%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year235.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-241.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-202.94%
OCF growth 3YN/A
OCF growth 5YN/A